 Survival patients immune deficiency syndrome Mycobacterium avium complex infection antimycobacterial chemotherapy contribution disseminated Mycobacterium avium complex DMAC infection morbidity mortality patients immune deficiency syndrome AIDS unclear Previous studies decreased survival patients AIDS DMAC incomplete information patient immunologic status follow-up patients AIDS DMAC survival AIDS patients DMAC comparable risk factors survival Case control subjects similar terms cell count prior AIDS status history antiretroviral therapy history Pneumocystis carinii prophylaxis year diagnosis group patients untreated DMAC survival mean months median months matched patients AIDS DMAC mean months median months survival additional patients DMAC antimycobacterial therapy mean months median months additional control subjects mean months median months Patients treated DMAC untreated DMAC untreated DMAC survival results patients DMAC antimycobacterial therapy shortened survival untreated DMAC